|
Group BA 24
|
Sample size
|
[3 H]DAMGO binding (fmole/mg ETE)
|
Analysis parameters
|
P value
|
|---|
|
Suicide
|
41
|
32.25 ± 1.76
|
t = 2.7, df = 120 (non-suicide)
|
0.008
|
|
Non-suicide
|
81
|
38.34 ± 1.34
| | |
|
Diagnosis/suicide
|
BA 24
| | | |
|
Controls
|
51
|
37.63 ± 1.83
| | |
|
Suicides
|
9
|
34.02 ± 3.80
|
t = 0.88 (controls)
|
n.s
|
|
MDD
|
5
|
27.95 ± 9.06
|
t = 1.84 (controls)
|
n.s
|
|
MDD (suicide)
|
15
|
35.69 ± 2.84
|
t = 0.58 (controls)
|
n.s
|
|
BP
|
8
|
50.51 ± 1.98
|
t = 3.00 (controls)
|
n.s
|
|
BP (suicide)
|
5
|
35.38 ± 3.07
|
t = 0.43 (controls)
|
n.s
|
|
Schizophrenia
|
26
|
37.80 ± 1.83
|
t = 0.04 (controls)
|
n.s
|
|
Schizophrenia (suicide)
|
12
|
25.31 ± 3.17
|
t = 3.39 (controls) t = 3.21 (schizophrenia)
|
<0.05
|
|
Schizophrenia/suicide
|
BA 9
| | | |
|
Controls
|
20
|
31.65 ± 2.11
| | |
|
Schizophrenia
|
26
|
34.40 ± 1.32
|
t = 1.15 (controls)
|
n.s
|
|
Schizophrenia (suicide)
|
12
|
24.12 ± 2.27
|
t = 2.57 (controls) t = 3.68 (schizophrenia)
|
<0.05 <0.05
|
| |
CPu
| | | |
|
Controls
|
20
|
25.40 ± 2.16
| | |
|
Schizophrenia
|
24
|
23.72 ± 1.37
|
t = 0.67 (controls)
|
n.s
|
|
Schizophrenia (suicide)
|
11
|
16.29 ± 2.42
|
t = 2.97 (controls) t = 2.50 (schizophrenia)
|
<0.05 <0.05
|
- The group comparison the analysis factors refer to is given in brackets below the parameters. Abbreviations: n.s. = not significant.
